Lucinda Bateman

Lucinda Bateman (Cindy Bateman), MD, is an ME/CFS physician and researcher. She founded and is Chief Medical Officer of the Bateman Horne Center of Excellence for ME/CFS and Fibromyalgia in Salt Lake City, Utah.

Dr. Bateman was one of the authors of the 2011 case definition, International Consensus Criteria, and was one of the experts on the "Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome" that was convened for the 2015 Institute of Medicine report.

Suzanne Vernon, PhD, the Research Liaison at Bateman Horne Center of Excellence works closely with Dr. Bateman on ME/CFS and fibromyalgia research.

Awards

 * 2016, Rudy Perpich Senior Lectureship Award, presented to a distinguished CFS/FMS scientist, physician or healthcare worker awarded by International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis

CFSAC committee
Dr. Bateman was a voting member of the Health and Human Services's Chronic Fatigue Syndrome Advisory Committee for the terms 12/01/05 to 12/01/08 & 01/03/06 to 01/03/10 and was serving the term 12/13/2017 to Sep 2020 when the committee was dissolved by HHS.

Journal editoral board
Dr. Bateman serves on the editorial board of the journal, Fatigue: Biomedicine, Health & Behavior.

ME/CFS Common Data Elements (CDE) Project
Member of the Pain Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.

Open letter to The Lancet
Two open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Bateman, along with 41 colleagues in the ME/CFS field, signed the second letter.
 * 10 February 2016, An open letter to The Lancet, again - Virology blog

Editorials

 * Aug 2019, Editorial: Advances in ME/CFS Research and Clinical Care - (Partial text)

Research studies

 * 2005, A team approach to treating CFS: Matching best medical practices to phases of illness.
 * 2010, Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome - (Full Text)
 * 2011, Absence of XMRV retrovirus and other murine leukemia virus-related viruses in patients with chronic fatigue syndrome - (Full Text)
 * 2011, Evidence for a heritable predisposition to Chronic Fatigue Syndrome - (Full Text)
 * 2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome - (Full Text)
 * 2012, A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus - (Full Text)
 * 2012, Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome - (Full Text)
 * 2013, Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome - (Full Text)
 * 2014, No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank - (Full Text)
 * 2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome - (Abstract)
 * 2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study - (Abstract)
 * 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness - (Full text)
 * 2016, Treatment of postural orthostatic tachycardia syndrome and management of myalgic encephalomyelitis/chronic fatigue syndrome following suspected West Nile virus infection - (Abstract)
 * 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study - (Abstract)
 * 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study - (Abstract)
 * 2017, Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome - (Full Text)
 * 2018, KPAX002 as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A prospective, randomized trial - (Full Text)
 * 2018, Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics - (Full Text)
 * 2019, Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning - (Full text)
 * Aug 2019, Editorial: Advances in ME/CFS Research and Clinical Care - (Full text)
 * 2019, Pilot assessment of low NK cell-mediated ADCC and FCGR3A genetics in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Based on inclusion of family members without ME/CFS as controls, low ADCC is unsuitable as a diagnostic biomarker - (Abstract)
 * 2019, Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - (Full text)
 * 2020, Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients - (Full text)

Clinic location
The Bateman Horne Center

24 S. 1100 E., Suite 205

Salt Lake City, Utah 84102

1-801-359-7400

Talks and interviews

 * 9 Sep 2014, Can ME/CFS and FM Research Help You Sleep?
 * 2015, Spoonie Radio Episode 10 Guest - Dr. Lucinda Bateman - Podcast and Full Text Transcript
 * 2016, Simple But Effective Tools for Management of ME/CFS and FM - Lucinda Bateman, MD
 * 2016, BHC Wings to Fly - Dr. Bateman
 * 2016, 12th International IACFS/ME Biennial Clinical and Research Conference, Emerging Science and Clinical Care, Paper presentation:Synergy Trial for CFS – a phase 2 study of low-dose methylphenidate plus mitochondrial support
 * 3-5 May 2018, ME/CFS Canadian Collaborative Team Conference - Speech title: Objective Diagnosis of ME/CFS

Webinars
Science to patients / Wetenschap voor patienten


 * 2015, 68. Introduction and diagnosis / intriductie en diagnose - Dr. Lucinda Bateman
 * 2015, 69. Autoimmunity in ME/cfs / Auto-immuniteit bij ME/cvs - Dr. Lucinda Bateman
 * 2015, 70. Neuroinflammation and ME/cfs / Neuro-inflammatie en ME/cvs - Dr. Lucinda Bateman
 * 2015, 71. ME/cfs and the Brain/ ME/cvs en de hersenen - Dr. Lucinda Bateman
 * 2015, 72. Gene-expression and exercise / gen-expressie en inspanning - Dr. Lucinda Bateman
 * 2015, 73. FAQs part 1 / Veel gestelde vragen deel 1 - Dr. Lucinda Bateman
 * 2015, 74. FAQs part 2 / Veel gestelde vragen deel 2 - Dr. Lucinda Bateman

Solve ME/CFS Initiative


 * Apr 17, 2015 "Will SEID Diagnostic Criteria Improve Diagnosis and Treatment?"
 * Nov 14, 2014 "Can ME CFS and Fibromyalgia Research Help You Sleep?"

Blog posts

 * 17 October 2016, Pearls of Wisdom from an ME/CFS Physician, part 1
 * 17 October 2016, Pearls of Wisdom from an ME/CFS Physician, part 2
 * 17 October 2016, Pearls of Wisdom from a CFS Physician, part 3

Online presence

 * PubMed - Lucinda Bateman
 * Twitter
 * Facebook
 * Website - Bateman Horne Center
 * YouTube

Learn more

 * Cort Johnson - Lucinda Bateman profile
 * Lucinda Bateman